The generic drug industry is warning that Democrats' drug pricing legislation would undercut their ability to compete against brand-name drugs, and some experts say they have a point.
READ MORE
Remember Me
4/5/2023Pandemic Saw Rise in Opioid Prescriptions Given After Childbirth
1 hour agoTag: Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure
1 hour agoNCPA Applauds New PBM Disclosure Rule
1 hour agoFree resource for patient questions on vaccines
12/4/2025HIPAA Breach in 2025? Notification to HHS is Required
The upcoming calendar is currently empty.
Click here to view past events and photos »